Mary Beattie, M.D.

Assistant Clinical Professor of Medicine, Step 4 Attending Physician, UCSF DGIM, UCSF Women's Health

Education

• Undegraduate: Duke University
• Medical School: Ohio State University College of Medicine
• Internship: University of California, Davis
• Residency: University of California, San Francisco PRIME program
• Fellowship: Women's Health, University of California, San Francisco, 2001-2003
• Masters: Clinical Research, University of California, San Francisco, 2004

Areas of Interest

• Women's health
• CAD in women
• Hormone replacement & alternatives
• Headache
• Breast cancer prevention

Current Academic and/or Research Activities

Dr. Beattie's research is in the field of breast cancer prevention. She is specifically interested in the role of endogenous hormones and their relationship to breast cancer risk, decision making in women at risk of breast cancer, and genetic predisposition to breast and ovarian cancer.

Dr. Beattie is the physician-consultant to the Cancer Risk Program at the UCSF Comprehensive Cancer Center and at San Francisco General Hospital. She interacts with genetic counsellors, oncologists, OB/GYN's and surgeons in this program. She practices primary care at the UCSF Women's Health Center, and her research is conducted at the UCSF Women's Health Clinical Research Center.

Dr. Beattie's teaching spans several disciplines: epidemiologic methods, women's health, general medicine, and cancer prevention. She teaches at the medical student, resident, and faculty levels. She has given grand rounds at UCSF and at several other hospitals on the following topics: Genetic counselling, headaches, post-menopausal hormone therapy, breast cancer prevention, coronary artery disease in women.

1. Stanley ML, Wells RL, Purdy AP, Holley WK, Pitt CG. Kinetic Study of the Reaction of (Me3SiCH)2AsH with Ph3Ga via 1H NMR Spectroscopy. Duke University Archives, Senior Research Thesis.

2. Nelson SD, Stanley ML, Love CJ, Coyne KS, Schaal SF. The Autonomic and Hemodynamic Effects of Oral Theophylline in Patients with Vasodepressor Syncope. Arch Intern Med 1991; 151: 2425-2429.

3. Grogin HR, Stanley ML, Eisenberg SJ, Horacek BM, Lesh MD. Improved Body Surface Mapping Criteria for Localization of Accessory Pathways in WPW Syndrome. Computers in Cardiology 1992, 255-258.

4. Beattie MS. Communicating Effectively with your Doctor. Women's Health Journal, 1997.

5. Beattie MS. Coronary Artery Disease in Women, Health Notes, California Board of Pharmacy, 1997.

6. Beattie MS, Redberg R. Coronary Heart Disease in Women: Hormone Replacement Therapy, Current Treatment Options in Cardiovascular Medicine 2002: 129-136.

7. Beattie MS, Shlipak MG, Liu H, Browner WB, Schiller NB, Whooley MA. CRP and Ischemia in Users and Nonusers of Beta Blockers and Statins: Data from The Heart and Soul Study, Circulation 107:245-250.

8. Beattie MS. Current Status of Postmenopausal Hormone Replacement, Advanced Studies in Medicine, April 2003.

9. Beattie MS, Metz L, Grady D, Fleischmann K, Redberg R. Systematic Review of the Accuracy of Exercise Myocardial Perfusion Imaging and Echocardiography for Diagnosis of Coronary Heart Disease in Women. AHRQ report, www.ahcpr.gov, 12/02.